Genome-wide association study of selenium concentrations

Human Molecular Genetics

Volumn 24, Issue 5, 2015, Pages 1469-1477

  Cornelis, Marilyn C ^a,b   Fornage, Myriam ^c   Foy, Millennia ^c   Xun, Pengcheng ^d   Gladyshev, Vadim N ^a   Morris, Steve ^e   Chasman, Daniel I ^a   Hu, Frank B ^a,b   Rimm, Eric B ^a,b   Kraft, Peter ^b   Jordan, Joanne M ^f,g   Mozaffarian, Dariush ^a,b,h   He, Ka ^d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d INDIANA UNIVERSITY   (United States)

^e UNIVERSITY OF MISSOURI   (United States)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^g IL   (United States)

^h TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BETAINE; HOMOCYSTEINE; SELENIUM; SELENOPROTEIN; THIOREDOXIN REDUCTASE 1; TXNRD1 PROTEIN, HUMAN;

ARTICLE; BLOOD SAMPLING; CLINICAL ASSESSMENT; CONCENTRATION RESPONSE; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); NAIL; NEUTRON ACTIVATION ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; QUALITY CONTROL; SELENIUM BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; CHEMISTRY; CORONARY ARTERY DISEASE; GENE LOCUS; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GENOTYPING TECHNIQUE; META ANALYSIS; METABOLISM;

CORONARY ARTERY DISEASE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GENOTYPING TECHNIQUES; HOMOCYSTEINE; HUMANS; NAILS; POLYMORPHISM, SINGLE NUCLEOTIDE; SELENIUM; SELENOPROTEINS; THIOREDOXIN REDUCTASE 1;

EID: 84924487634     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddu546     Document Type: Article

References (65)

1. Stranges, S., Navas-Acien, A., Rayman, M.P. and Guallar, E. (2010) Selenium status and cardiometabolic health: state of the evidence. Nutr. Metab. Cardiovasc. Dis., 20, 754-760.
2. Rayman, M.P. (2012) Selenium and human health. Lancet, 379, 1256-1268.
3. Hatfield, D.L. and Gladyshev, V.N. (2009) The Outcome of Selenium and Vitamin E Cancer Prevention Trial (SELECT) reveals the need for better understanding of selenium biology. Mol. Interv., 9, 18-21.
4. Rees, K., Hartley, L., Day, C., Flowers, N., Clarke, A. and Stranges, S. (2013) Selenium supplementation for the primary prevention of cardiovascular disease. Cochrane Database Syst. Rev., 1, CD009671.
5. Rocourt, C.R. and Cheng,W.H. (2013) Seleniumsupranutrition: are the potential benefits of chemoprevention outweighed by the promotion of diabetes and insulin resistance? Nutrients, 5, 1349-1365.
6. Evans, D.M., Zhu, G., Dy, V., Heath, A.C., Madden, P.A., Kemp, J. P., McMahon, G., St Pourcain, B., Timpson, N.J., Golding, J. et al. (2013) Genome-wide association study identifies loci affecting blood copper, selenium and zinc. Hum. Mol. Genet., 22, 3998-4006.
7. Satia, J.A., King, I.B., Morris, J.S., Stratton, K. and White, E. (2006) Toenail and plasma levels as biomarkers of selenium exposure. Ann. Epidemiol., 16, 53-58.
8. Al-Saleh, I. and Billedo, G. (2006) Determination of selenium concentration in serum and toenail as an indicator of selenium status. Bull. Environ. Cont. Toxicol., 77, 155-163.
9. Westra, H.J., Peters, M.J., Esko, T., Yaghootkar, H., Schurmann, C., Kettunen, J., Christiansen, M.W., Fairfax, B.P., Schramm, K., Powell, J.E. et al.(2013) Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat. Genet., 45, 1238-1243.
10. van Meurs, J.B., Pare, G., Schwartz, S.M., Hazra, A., Tanaka, T., Vermeulen, S.H., Cotlarciuc, I., Yuan, X., Malarstig, A., Bandinelli, S. et al.(2013) Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease. Am. J. Clin. Nutr., 98, 668-676.
11. Pare, G., Chasman, D.I., Parker, A.N., Zee, R.R., Malarstig, A., Seedorf, U., Collins, R., Watkins, H., Hamsten, A., Miletich, J. P. et al.(2009) Novel associations of CPS1, MUT, NOX4, and DPEP1 with plasma homocysteine in a healthy population: a genome-wide evaluation of 13 974 participants in the Women's Genome Health Study. Circ. Cardiovasc. Genet., 2, 142-150.
12. Fairweather-Tait, S.J., Bao, Y., Broadley, M.R., Collings, R., Ford, D., Hesketh, J.E. and Hurst, R. (2011) Selenium in human health and disease. Antioxid. Redox Signal., 14, 1337-1383.
13. Harrison, I., Littlejohn, D. and Fell, G.S. (1996) Distribution of selenium in human blood plasma and serum. Analyst, 121, 189-194.
14. Burk, R.F., Hill, K.E. and Motley, A.K. (2001) Plasma selenium in specific and non-specific forms. BioFactors (Oxford, England), 14, 107-114.
15. Longnecker, M.P., Stram, D.O., Taylor, P.R., Levander, O.A., Howe, M., Veillon, C., McAdam, P.A., Patterson, K.Y., Holden, J.M., Morris, J.S. et al.(1996) Use of selenium concentration in whole blood, serum, toenails, or urine as a surrogate measure of selenium intake. Epidemiology, 7, 384-390.
16. Gong, J., Hsu, L., Harrison, T., King, I.B., Sturup, S., Song, X., Duggan, D., Liu, Y., Hutter, C., Chanock, S.J. et al.(2013) Genome-wide association study of serum selenium concentrations. Nutrients, 5, 1706-1718.
17. Finkelstein, J.D. (2000) Pathways and regulation of homocysteine metabolism in mammals. Semin. Thromb. Hemost., 26, 219-225.
18. Mudd, S.H., Ebert, M.H. and Scriver, C.R. (1980) Labile methyl group balances in the human: the role of sarcosine. Metabolism, 29, 707-720.
19. Hoffer, L.J. (2004) Homocysteine remethylation and trans-sulfuration. Metabolism, 53, 1480-1483.
20. Ohta, Y. and Suzuki, K.T. (2008) Methylation and demethylation of intermediates selenide and methylselenol in the metabolism of selenium. Toxicol. Appl. Pharmacol., 226, 169-177.
21. Jackson, M.I., Lunoe, K., Gabel-Jensen, C., Gammelgaard, B. and Combs, G.F. Jr. (2013) Metabolism of selenite to selenosugar and trimethylselenonium in vivo: tissue dependency and requirement for S-adenosylmethionine-dependent methylation. J. Nutr. Biochem., 24, 2023-2030.
22. Nicastro, H.L. and Dunn, B.K. (2013) Selenium and prostate cancer prevention: insights from the selenium and vitamin E cancer prevention trial (SELECT). Nutrients, 5, 1122-1148.
23. Esaki, N., Nakamura, T., Tanaka, H., Suzuki, T., Morino, Y. and Soda, K. (1981) Enzymatic synthesis of selenocysteine in rat liver. Biochemistry, 20, 4492-4496.
24. Beilstein, M., Gahl, W. and Whanger, P. (1988) In Hurley, L., Keen, C., Lonnerdal, B. and Rucker, R. (eds), Trace Elements in Man and Animals 6, Springer, New York, pp. 323-324.
25. Feng, Q., Kalari, K., Fridley, B.L., Jenkins, G., Ji, Y., Abo, R., Hebbring, S., Zhang, J., Nye, M.D., Leeder, J.S. et al.(2011) Betaine-homocysteine methyltransferase: human liver genotype-phenotype correlation. Mol. Genet. Metab., 102, 126-133.
26. Xie, W., Wood, A.R., Lyssenko, V., Weedon, M.N., Knowles, J. W., Alkayyali, S., Assimes, T.L., Quertermous, T., Abbasi, F., Paananen, J. et al.(2013) Genetic variants associated with glycine metabolism and their role in insulin sensitivity and type 2 diabetes. Diabetes, 62, 2141-2150.
27. Suhre, K., Shin, S.Y., Petersen, A.K., Mohney, R.P., Meredith, D.,Wagele, B., Altmaier, E., Deloukas, P., Erdmann, J., Grundberg, E. et al.(2011) Human metabolic individuality in biomedical and pharmaceutical research. Nature, 477, 54-60.
28. Szegedi, S.S., Castro, C.C., Koutmos, M. and Garrow, T.A. (2008) Betaine-homocysteine S-methyltransferase-2 is an Smethylmethionine-homocysteine methyltransferase. J. Biol. Chem., 283, 8939-8945.
29. Gopalakrishna, R., Gundimeda, U. and Chen, Z.H. (1997) Cancer-preventive selenocompounds induce a specific redox modification of cysteine-rich regions in Ca2+-dependent isoenzymes of protein kinase C. Arch. Biochem. Biophys., 348, 25-36.
30. Uthus, E.O., Yokoi, K. and Davis, C.D. (2002) Selenium deficiency in Fisher-344 rats decreases plasma and tissue homocysteine concentrations and alters plasma homocysteine and cysteine redox status. J. Nutr., 132, 1122-1128.
31. Reszka, E., Jablonska, E., Gromadzinska, J. and Wasowicz, W. (2012) Relevance of selenoprotein transcripts for selenium status in humans. Genes Nutr., 7, 127-137.
32. Wald, D.S., Law, M. and Morris, J.K. (2002) Homocysteine and cardiovascular disease: evidence on causality from a metaanalysis. BMJ, 325, 1202.
33. Gonzalez, S., Huerta, J.M., Alvarez-Uria, J., Fernandez, S., Patterson, A.M. and Lasheras, C. (2004) Serum selenium is associated with plasma homocysteine concentrations in elderly humans. J. Nutr., 134, 1736-1740.
34. Uthus, E.O. and Ross, S.A. (2007) Dietary selenium affects homocysteine metabolism differently in Fisher-344 rats and CD-1 mice. J. Nutr., 137, 1132-1136.
35. Wolf, N.M., Mueller, K., Hirche, F., Most, E., Pallauf, J. and Mueller, A.S. (2010) Study of molecular targets influencing homocysteine and cholesterol metabolism in growing rats by manipulation of dietary selenium and methionine concentrations. Br. J. Nutr., 104, 520-532.
36. Venn, B.J., Grant, A.M., Thomson, C.D. and Green, T.J. (2003) Selenium supplements do not increase plasma total homocysteine concentrations in men and women. J. Nutr., 133, 418-420.
37. Bekaert, B., Cooper, M.L., Green, F.R., McNulty, H., Pentieva, K., Scott, J.M., Molloy, A.M. and Rayman, M.P. (2008) Effect of selenium status and supplementation with high-selenium yeast on plasma homocysteine and B vitamin concentrations in the UK elderly. Mol. Nutr. Food Res., 52, 1324-1333.
38. Davis, C.D. and Uthus, E.O. (2003) Does dietary selenium affect plasma homocysteine concentrations in humans? J. Nutr., 133, 2392; author reply 2393.
39. Teng, Y.W., Cerdena, I. and Zeisel, S.H. (2012) Homocysteinemia in mice with genetic betaine homocysteine S-methyltransferase deficiency is independent of dietary folate intake. J. Nutr., 142, 1964-1967.
40. Liang, S., Zhou, Y., Wang, H., Qian, Y., Ma, D., Tian, W., Persaud-Sharma, V., Yu, C., Ren, Y., Zhou, S. et al.(2014) The effect of multiple single nucleotide polymorphisms in the folic acid pathway genes on homocysteine metabolism. BioMed Res. Int., 2014, 560183.
41. Clifford, A.J., Chen, K., McWade, L., Rincon, G., Kim, S.H., Holstege, D.M., Owens, J.E., Liu, B., Muller, H.G., Medrano, J. F. et al.(2012) Gender and single nucleotide polymorphisms in MTHFR, BHMT, SPTLC1, CRBP2, CETP, and SCARB1 are significant predictors of plasma homocysteine normalized by RBC folate in healthy adults. J. Nutr., 142, 1764-1771.
42. Fredriksen, A., Meyer, K., Ueland, P.M., Vollset, S.E., Grotmol, T. and Schneede, J. (2007) Large-scale population-based metabolic phenotyping of thirteen genetic polymorphisms related to one-carbon metabolism. Hum. Mutat., 28, 856-865.
43. Friedman, G.D., Cutter, G.R., Donahue, R.P., Hughes, G.H., Hulley, S.B., Jacobs, D.R. Jr., Liu, K. and Savage, P.J. (1988) CARDIA: study design, recruitment, and some characteristics of the examined subjects. J. Clin. Epidemiol., 41, 1105-1116.
44. Jordan, J.M., Helmick, C.G., Renner, J.B., Luta, G., Dragomir, A. D., Woodard, J., Fang, F., Schwartz, T.A., Abbate, L.M., Callahan, L.F. et al.(2007) Prevalence of knee symptoms and radiographic and symptomatic knee osteoarthritis in African Americans and Caucasians: the Johnston County Osteoarthritis Project. J. Rheumatol., 34, 172-180.
45. Colditz, G.A. and Hankinson, S.E. (2005) The Nurses' Health Study: lifestyle and health among women. Nat. Rev. Cancer, 5, 388-396.
46. Laurie, C.C., Doheny, K.F., Mirel, D.B., Pugh, E.W., Bierut, L.J., Bhangale, T., Boehm, F., Caporaso, N.E., Cornelis, M.C., Edenberg, H.J. et al.(2010) Quality control and quality assurance in genotypic data for genome-wide association studies. Genet. Epidemiol., 34, 591-602.
47. Jensen, M.K., Pers, T.H., Dworzynski, P., Girman, C.J., Brunak, S. and Rimm, E.B. (2011) Protein interaction-based genomewide analysis of incident coronary heart disease. Circ. Cardiovasc. Genet., 4, 549-556.
48. Hunter, D.J., Kraft, P., Jacobs, K.B., Cox, D.G., Yeager, M., Hankinson, S.E., Wacholder, S., Wang, Z., Welch, R., Hutchinson, A. et al.(2007) A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat. Genet., 39, 870-874.
49. Chu, N.F., Spiegelman, D., Yu, J., Rifai, N., Hotamisligil, G.S. and Rimm, E.B. (2001) Plasma leptin concentrations and four-year weight gain among US men. Int. J. Obes. Relat. Metab. Disord., 25, 346-353.
50. Park, K., Rimm, E.B., Siscovick, D.S., Spiegelman, D., Manson, J.E., Morris, J.S., Hu, F.B. and Mozaffarian, D. (2012) Toenail selenium and incidence of type 2 diabetes in U.S. men and women. Diabetes Care, 35, 1544-1551.
51. Xun, P., Bujnowski,D., Liu,K., Morris, J.S., Guo, Z. andHe, K. (2011) Distribution of toenail selenium levels in young adult Caucasians and African Americans in the United States: the CARDIA Trace Element Study. Environ. Res., 111, 514-519.
52. Jordan, J., Fang, F., Arab, L., Morris, S., Renner, J., Helmick, C. and Hochberg, M. (2005) Low selenium levels are associated with increased risk for osteoarthritis of the knee. Arthritis Rheum., 52, S455.
53. Ashton, K., Hooper, L., Harvey, L.J., Hurst, R., Casgrain, A. and Fairweather-Tait, S.J. (2009) Methods of assessment of selenium status in humans: a systematic review. Am. J. Clin. Nutr., 89, 2025S-2039S.
54. Morris, J., Stampfer, M. and Willett, W. (1983) Dietary selenium in humans toenails as an indicator. Biol. Trac. Elem. Res., 5, 529-537.
55. Lemaitre, R.N., Tanaka, T., Tang,W., Manichaikul, A., Foy, M., Kabagambe, E.K., Nettleton, J.A., King, I.B.,Weng, L.C., Bhattacharya, S. et al.(2011) Genetic loci associated with plasma phospholipid n-3 fatty acids: a meta-analysis of genomewide association studies from the CHARGE Consortium. PLoS Genet., 7, e1002193.
56. Sorge, R.E., Trang, T., Dorfman, R., Smith, S.B., Beggs, S., Ritchie, J., Austin, J.S., Zaykin, D.V., Vander Meulen, H., Costigan, M. et al.(2012) Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity. Nat. Med., 18, 595-599.
57. Price, A.L., Patterson, N.J., Plenge, R.M., Weinblatt, M.E., Shadick, N.A. and Reich, D. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet., 38, 904-909.
58. Li, Y. and Abecasis, G.R. (2006) Mach 1.0: rapid haplotype reconstruction and missing genotype inference. Am. J. Hum. Genet., S79, 2290.
59. Browning, B.L. and Browning, S.R. (2009) A unified approach to genotype imputation and haplotype-phase inference for large data sets of trios and unrelated individuals. Am. J. Hum. Genet., 84, 210-223.
60. Aulchenko, Y.S., Struchalin, M.V. and van Duijn, C.M. (2010) ProbABEL package for genome-wide association analysis of imputed data. BMC Bioinformatics, 11, 134.
61. Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A., Bender, D., Maller, J., Sklar, P., de Bakker, P.I., Daly, M.J. et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet., 81, 559-575.
62. Ioannidis, J.P., Patsopoulos, N.A. and Evangelou, E. (2007) Heterogeneity in meta-analyses of genome-wide association investigations. PLoS ONE, 2, e841.
63. Pe'er, I., Yelensky, R., Altshuler, D. and Daly, M.J. (2008) Estimation of the multiple testing burden for genomewide association studies of nearly all common variants. Genet. Epidemiol., 32, 381-385.
64. Liu, J.Z., McRae, A.F., Nyholt, D.R., Medland, S.E., Wray, N.R., Brown, K.M., Hayward, N.K., Montgomery, G.W., Visscher, P. M.,Martin, N.G. et al.(2010) Aversatile gene-based test for genome-wide association studies. Am. J. Hum. Genet., 87, 139-145.
65. Segre, A.V., Groop, L., Mootha, V.K., Daly, M.J. and Altshuler, D. (2010) Common inherited variation in mitochondrial genes is not enriched for associations with type 2 diabetes or related glycemic traits. PLoS Genet., 6, e1001058.